ArticleMolecular oncology2022

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.

Tiziana Triulzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.